| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |